Valion Bio, Inc. (VBIO)
NCM · Healthcare · Biotechnology
$0.96
-14.63%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.9M
Shares Outstanding
1.9M
P/S (TTM)
-11.9x
Exchange
NCM
Currency
USD
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 146K | (302K) | 0.00 | 0.00 |
| Gross Profit | (145K) | |||
| Operating Income | (2.5M) | (2.0M) | (5.6M) | (6.4M) |
| Net Income | (2.6M) | (2.8M) | (6.2M) | (7.1M) |
| Diluted EPS | $-49.25 | N/A | $-55.75 | $-54.25 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 1.8M | 1.2M | 0.00 | 0.00 |
| Gross Profit | 299K | 287K | 2K | |
| Operating Income | (10.1M) | (8.2M) | (4.5M) | (7.9M) |
| Net Income | (10.1M) | (8.2M) | (5.7M) | (8.9M) |
| Diluted EPS | $-44,475.77 | $-4,420.00 | $-492.00 | $-196.00 |